| Chang Y |
------>authors3_c=??? ------>paper_class1=1 ------>Impact_Factor=1.397 ------>paper_class3=2 ------>paper_class2=1 ------>vol=28 ------>confirm_bywho=chlin ------>insert_bywho=sheujr ------>Jurnal_Rank=37.9 ------>authors4_c=??? ------>comm_author=1 ------>patent_EDate=None ------>authors5_c=??? ------>publish_day=1 ------>paper_class2Letter=None ------>page2=333 ------>medlineContent= ------>unit=E1300 ------>insert_date=20071204 ------>iam=7 ------>update_date=None ------>author=??? ------>change_event=4 ------>ISSN= ------>authors_c=?? ------>score=384 ------>journal_name=Acta Pharmacol. Sin ------>paper_name=Tetramethylpyrazine suppresses the HIF-1?, TNF-?, and active caspase-3 expressions in middle cerebral artery occlusion-induced brain ischemia in rats ------>confirm_date=20071215 ------>tch_id=082005 ------>pmid=17302993 ------>page1=327 ------>fullAbstract=AIM: To examine the detailed mechanisms underlying the inhibitory effect of tetramethylpyrazine (TMPZ) in inflammatory and apoptotic responses induced by middle cerebral artery occlusion (MCAO) in rats. METHODS: MCAO-induced focal cerebral ischemia in rats was used in this study. The hypoxia-inducible factor-1alpha(HIF-1alpha), activation of caspase-3, and TNF-alpha mRNA transcription in ischemic regions were detected by immunoblotting and RT-PCR, respectively. Anti-oxidative activity was investigated using a thiobarbituric acid-reactive substance (TBARS) test in rat brain homogenate preparations. RESULTS: We showed the statistical results of the infarct areas of solvent- and TMPZ (20 mg/kg)-treated groups at various distances from the frontal pole in MCAO-induced focal cerebral ischemia in rats. Treatment with TMPZ (20 mg/kg) markedly reduced the infarct area in all regions, especially in the third to fifth sections. MCAO-induced focal cerebral ischemia was associated with increases in HIF-1alpha and the activation of caspase-3, as well as TNF-alpha transcription in ischemic regions. These expressions were markedly inhibited by treatment with TMPZ (20 mg/kg). However, TMPZ (0.5-5 mmol/L) did not significantly inhibit TBARS reaction in rat brain homogenates. CONCLUSION: The neuroprotective effect of TMPZ may be mediated at least by a portion of the inhibition of HIF-1alpha and TNF-alpha activations, followed by the inhibition of apoptosis formation (active caspase-3), resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury. Thus, TMPZ treatment may represent an ideal approach to lowering the risk of or improving function in ischemia- reperfusion brain injury-related disorders. ------>tmu_sno=None ------>sno=16352 ------>authors2=Hsiao G ------>authors3=Chen YC ------>authors4=Lin JH ------>authors5=Lin KH ------>authors6=Chou DS, Sheu JR ------>authors6_c=???, ??? ------>authors=Chang Y ------>delete_flag=0 ------>SCI_JNo=None ------>authors2_c=??? ------>publish_area=0 ------>updateTitle=Tetramethylpyrazine suppresses HIF-1alpha, TNF-alpha, and activated caspase-3 expression in middle cerebral artery occlusion-induced brain ischemia in rats. ------>language=2 ------>check_flag=None ------>submit_date=None ------>country=None ------>no=3 ------>patent_SDate=None ------>update_bywho=None ------>publish_year=2007 ------>submit_flag=None ------>publish_month=5 |